Breast Cancer Trial, Recruiting (NCT06721936)

Breast Cancer Trial, Recruiting NCT06721936 Sponsor: University of Alcala Condition: Breast Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT06721936 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Breast Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have had breast cancer and, as a result of your cancer treatment, are experiencing symptoms affecting the vagina and urinary area (such as dryness, discomfort, or irritation).
A specific assessment of vaginal health (called the Vaginal Health Index) has given you a score of 15 or below, indicating these symptoms are present (confirm with trial site).

Who may not be able to join:

You have previously had treatment or surgery to address pelvic floor problems or the vaginal/urinary symptoms mentioned above.
You are currently receiving chemotherapy, or you have had breast cancer surgery but have not yet received chemotherapy or hormone-based treatment.
You have other serious health conditions that could affect the study, such as a return of your cancer, ongoing or repeated urinary tract infections that are not being treated, blood in your urine, or any cognitive (thinking or memory) difficulties that would make it hard to understand the study, fill in questionnaires, give your consent, or take part fully.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 5 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 34918854828

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06721936

Sponsor: University of Alcala

Phase: Not Applicable

Status: Recruiting

Condition: Breast Cancer

Trial contact: 34918854828

More information: https://clinicaltrials.gov/study/NCT06721936

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have had breast cancer and, as a result of your cancer treatment, are experiencing symptoms affecting the vagina and urinary area (such as dryness, discomfort, or irritation).
A specific assessment of vaginal health (called the Vaginal Health Index) has given you a score of 15 or below, indicating these symptoms are present (confirm with trial site).

Who may not be able to join:

You have previously had treatment or surgery to address pelvic floor problems or the vaginal/urinary symptoms mentioned above.
You are currently receiving chemotherapy, or you have had breast cancer surgery but have not yet received chemotherapy or hormone-based treatment.
You have other serious health conditions that could affect the study, such as a return of your cancer, ongoing or repeated urinary tract infections that are not being treated, blood in your urine, or any cognitive (thinking or memory) difficulties that would make it hard to understand the study, fill in questionnaires, give your consent, or take part fully.

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 5 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

University of Alcala

Registry

ClinicalTrials.gov

Start date

29 November 2024

Est. completion

31 December 2027

Where this trial is recruiting

🇪🇸 Spain

Primary endpoints

Female Sexual Function (FSFI); Subjective Pelvic Perineal Pain Intensity; Health-Related Quality of Life (HRQoL)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 5 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov